Description to come
4 min read |Annual MeetingProf. Willy A. Flegel, MD, selected as the 2026 recipient of the Dale A. Smith Memorial Award in recognition of his original scientific and clinical contributions within the field of molecular immunohematology.
4 min read |FeatureDescription to come
6 min read |In ConversationDescription to come
5 min read |Members Only |Be WellDescription to come
9 min read |Insider's ViewJulia Z. Xu, MD, MScGH, discusses the potential impact of her research on transfusion management in sickle cell disease.
5 min read |Members Only |AABB Foundation: Shaping the IndustryOf Note: News stories from the field.
5 min read |Members Only |Of NoteExperts discuss the benefits and limitations of available therapies, as well as the importance of shared decision-making, individualized treatment plans and earlier intervention.
10 min read |Members Only |FeatureA mother with sickle cell disease and two specialists discuss the role of transfusion support and multidisciplinary care to improve outcomes for mothers and babies.
11 min read |Open Access |FeatureIn this month's President's message, Jose Cancelas, MD, PhD, CABP, discusses how advances in research, treatment and comprehensive care are expanding possibilities for people living with sickle cell disease.
3 min read |Open Access |President’s MessageAABB Premium Corporate Partner QuidelOrtho has partnered with blood banks and hospital laboratories to provide safe and compatible blood to labs that ensure patients receive it when they need it most.
5 min read |Corporate Partner SpotlightTara King shares how her mother's experience with sickle cell disease inspired her career path at OneBlood.
6 min read |Open Access |FeatureAmy Cohen shares her journey of becoming the first person with sickle cell disease to complete a marathon.
7 min read |Open Access |FeatureVitalant’s sickle cell disease initiative aims to align recruitment, hospital engagement, inventory management and clinical support across a national system to improve care for patients with SCD.
3 min read |Open Access |In the FieldFor patients with sickle cell disease, the discussion surrounding “fresh blood” is no longer simply about inventory management. It becomes a debate about biology, equity, scarcity and, arguably, justice.
8 min read |Members Only |The Ethical Pulse: Blood, Biotherapies & BeyondMatthew S. Karafin, MD, MS, discusses the inspiration for his career path and his research on red blood storage age and red cell quality in patients with sickle cell disease.
4 min read |Members Only |White CoatsA husband-and-wife team in Switzerland recently launched a community-focused app to help sickle cell warriors manage their health and advocate for better care.
8 min read |Open Access |In ConversationThe best budget is not the most detailed one. It is the one you can consistently follow month after month.
4 min read |Members Only |Be Well"Through AABB, I have learned how essential community, mentorship and shared purpose are to advancing transfusion medicine."
3 min read |Members Only |Membership Focus
Transfusion is AABB’s scholarly, peer-reviewed monthly journal, publishing the latest on technological advances, clinical research and controversial issues related to transfusion medicine, blood banking, biotherapies and tissue transplantation. Access of Transfusion is free to all AABB members.
Learn More About Transfusion Journal
Keep abreast of what's happening in the field of biotherapies with CellSource - AABB's monthly update on the latest biotherapies news.
To submit news about the blood and biotherapies field to AABB, please email news@aabb.org.